Cargando…

Immunomodulation by imiquimod in patients with high-risk primary melanoma

Imiquimod is a synthetic Toll-like receptor 7 (TLR7) agonist approved for the topical treatment of actinic keratoses, superficial basal cell carcinoma, and genital warts. Imiquimod leads to an 80–100% cure rate of lentigo maligna, but studies of invasive melanoma are lacking. We conducted a pilot st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narayan, Rupa, Nguyen, Hong, Bentow, Jason J., Moy, Lauren, Lee, Diana K., Greger, Stephanie, Haskell, Jacquelyn, Vanchinathan, Veena, Chang, Pei-Lin, Tsui, Shanli, Konishi, Tamiko, Comin-Anduix, Begonya, Dauphine, Christine, Vargas, Hernan I., Economou, James S., Ribas, Antoni, Bruhn, Kevin W., Craft, Noah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229834/ https://www.ncbi.nlm.nih.gov/pubmed/21850019 http://dx.doi.org/10.1038/jid.2011.247

Ejemplares similares

LXR Deficiency Confers Increased Protection against Visceral Leishmania Infection in Mice
por: Bruhn, Kevin W., et al.
Publicado: (2010)

Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma
por: Homet Moreno, Blanca, et al.
Publicado: (2015)

Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma
por: Lassen, Amanda, et al.
Publicado: (2014)

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
por: von Euw, Erika, et al.
Publicado: (2009)

A kinetic investigation of interacting, stimulated T cells identifies conditions for rapid functional enhancement, minimal phenotype differentiation, and improved adoptive cell transfer tumor eradication
por: Zhou, Jing, et al.
Publicado: (2018)

Immunomodulating Therapy by Picibanil-based Imiquimod and Virotherapy for Advanced Uterine Cancer after Laparoscopic Surgery
por: Peng, Hsiu-Huei, et al.
Publicado: (2021)

Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes
por: Robert, Lidia, et al.
Publicado: (2014)

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
por: Atefi, Mohammad, et al.
Publicado: (2015)

Beyond the immediate tumor microenvironment: distinct T cell phenotype and function of tumor-adjacent healthy breast tissue associated with regional metastasis in breast cancer
por: Guo, Yi, et al.
Publicado: (2014)

Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway
por: Atefi, Mohammad, et al.
Publicado: (2011)

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
por: Niehr, Franziska, et al.
Publicado: (2011)

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
por: Wong, Deborah JL, et al.
Publicado: (2014)

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
por: Wong, Deborah JL, et al.
Publicado: (2015)

Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products
por: Nowicki, Theodore S., et al.
Publicado: (2018)

Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998)

Tremelimumab: research and clinical development
por: Comin-Anduix, Begoña, et al.
Publicado: (2016)

A gene-expression program reflecting the innate immune response of cultured intestinal epithelial cells to infection by Listeria monocytogenes
por: Baldwin, David N, et al.
Publicado: (2003)

Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure
por: Shin, Daniel, et al.
Publicado: (2015)

Topical Imiquimod Treatment of Lentigo Maligna
por: Ventura, F., et al.
Publicado: (2009)

Bowen's Disease Treated with Imiquimod and Cryotherapy
por: Patel, Krina B
Publicado: (2012)

Melanoma Arising after Imiquimod Use
por: Paul, Sharad P.
Publicado: (2014)

Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma
por: Comin-Anduix, Begoña, et al.
Publicado: (2008)

HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
por: Curtin, James F, et al.
Publicado: (2009)

Topical Application of Imiquimod as a Treatment for Chromoblastomycosis
por: de Sousa, Maria da Glória Teixeira, et al.
Publicado: (2014)

Erosive Pustular Dermatosis of the Scalp Induced by Imiquimod
por: Corradin, Maria Teresa, et al.
Publicado: (2012)

Imiquimod - Its role in the treatment of cutaneous malignancies
por: Bubna, Aditya Kumar
Publicado: (2015)

Inverted follicular keratosis successfully treated with imiquimod
por: Karadag, Ayse Serap, et al.
Publicado: (2016)

Bowen's disease: A favorable response to imiquimod
por: Barad, Prachi, et al.
Publicado: (2014)

Miscellaneous Antiviral Agents (Interferons, Imiquimod, Pleconaril)
por: Dolin, Raphael
Publicado: (2015)

A Perspective on Imiquimod Microneedles for Treating Warts
por: Chiu, Tsu-Man, et al.
Publicado: (2021)

Lichenoid keratosis successfully treated with topical imiquimod
por: BinJadeed, Hessah, et al.
Publicado: (2020)

Phospholipid-Based Microemulsions for Cutaneous Imiquimod Delivery
por: Panoutsopoulou, Eleni, et al.
Publicado: (2022)

Pseudolymphoma of the nipple treated with topical imiquimod and cryotherapy
por: Xiao, Amy, et al.
Publicado: (2022)

The Concept and Practice of Immunomodulation in Ayurveda and the Role of Rasayanas as Immunomodulators
por: Tripathi, J.S., et al.
Publicado: (1999)

Advances in the use of topical imiquimod to treat dermatologic disorders
por: Lacarrubba, Francesco, et al.
Publicado: (2008)

Effect of imiquimod on cytokine induction in first trimester trophoblasts.
por: Manlove-Simmons, J M, et al.
Publicado: (2000)

GENITAL VITILIGO FOLLOWING USE OF IMIQUIMOD 5% CREAM
por: Zhang, Ruzhi, et al.
Publicado: (2011)

Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
por: Alessi, Sabrina Sisto, et al.
Publicado: (2009)

Penile pyoderma gangrenosum successfully treated with topical Imiquimod
por: Rathod, Santosh P., et al.
Publicado: (2011)

Management of superficial basal cell carcinoma: focus on imiquimod
por: Raasch, Beverly
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sceadio76dvc7cddg2tqul5ok5